Related Experiment Video
Updated: Dec 25, 2025

06:27
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
979
5-Azacitidine in patients with IDH1/2-mutant recurrent glioma
Laetitia Federici1, Laurent Capelle2, Maxime Annereau1
1Pharmacy Clinical Service, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France.
Neuro-Oncology
|March 28, 2020
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
354
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
354

